Podcast appearances and mentions of Corey A Siegel

Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Corey A. Siegel, MD, MS Predicting which patients with IBD will develop complications allows for much better medication choices. But how do we go about predicting that risk? Joining Dr. Peter Buch to tackle this topic is Dr. Corey Siegel, Section Chief of Gastroenterology and Hepatology at Dartmouth-Hitchcock Medical Center.

Host: Matt Birnholz, MD Guest: Corey A. Siegel, MD, MS At the third annual Crohn’s & Colitis Congress in Austin, Texas, Co-Director of the IBD Program and Section Chief of Gastroenterology and Hepatology at the Dartmouth-Hitchcock Medical Center Dr. Corey Siegel sat down with Dr. Matt Birnholz to share his approach to presenting risk data to his IBD patients.

Host: Matt Birnholz, MD Guest: Corey A. Siegel, MD, MS At the third annual Crohn’s & Colitis Congress in Austin, Texas, Co-Director of the IBD Program and Section Chief of Gastroenterology and Hepatology at the Dartmouth-Hitchcock Medical Center Dr. Corey Siegel sat down with Dr. Matt Birnholz to share his approach to presenting risk data to his IBD patients.

Medicine Grand Rounds January 12, 2018 Corey A. Siegel, MD, MS Associate Professor of Medicine Associate Professor of The Dartmouth Institute for Health Policy and Clinical Practice The Geisel School of Medicine at Dartmouth Chief, Section of Gastroenterology and Hepatology Dartmouth-Hitchcock Medical Center

An editorial in the April issue of Gastroenterology compares anti-tumor necrosis factor monotherapy with combination therapy for inflammatory bowel disease. Dr. Kuemmerle speaks with co-author Dr. Corey A. Siegel